Panacea Life Sciences Holdings, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Panacea Life Sciences Holdings, Inc. (PLSH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.10 per share for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2021-08-23
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $0.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.10 10-Q · filed 2021-08-23 | |||
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-27 | |||
| 2020-09-30 | $0.30 10-Q · filed 2020-11-18 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-03-29 |